Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Labopharm | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Labopharm

Mark D’Souza has been appointed president and chief executive officer of Labopharm and a member of the board of directors.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Mark D’Souza has been appointed president and chief executive officer of Labopharm and a member of the board of directors. Mr. D’Souza previously served as the company’s chief financial officer. “We are delighted to have Mark’s knowledge and experience to lead the corporation forward,” said Santo J. Costa, Labopharm’s chairman.

Mr. D’Souza replaces James Howard-Tripp, who will step down from his role. “We are very grateful to Jim for his efforts on behalf of the Corporation over the last 11 years,” said Mr. Costa.

Labopharm also announced that the board of directors, together with the company’s management, has undertaken a complete review of the business, including consideration of all available strategic options.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters